報價延遲最少15分鐘:2025/08/25 12:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.2667 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-12,356.89/3.14
|
|
企業價值
4.47M
|
| 資產負債 |
|
每股賬面淨值
8.61
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
520.00K
|
|
每股收益
1.21
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/08/25 12:32 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. |
